Divyan Chopra

No ORCID on file · 9 papers in corpus · active 2020

Study types

  • article 5
  • other 4

Condition tags

  • endometriosis 9
other 2020
Healthcare Resource Use and Costs Associated with Opioid Initiation among Newly Diagnosed Endometriosis Patients with Commercial Insurance in the US
·doi:10.6084/m9.figshare.12173388

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

other 2020
Healthcare Resource Use and Costs Associated with Opioid Initiation among Newly Diagnosed Endometriosis Patients with Commercial Insurance in the US
·doi:10.6084/m9.figshare.12173388.v1

The above summary slide represents the opinions of the authors. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite). © The …

article 2020
Healthcare Resource Use and Costs Associated with Opioid Initiation Among Patients with Newly Diagnosed Endometriosis with Commercial Insurance in the USA
Advances in therapy ·doi:10.1007/s12325-020-01361-7

INTRODUCTION: To compare all-cause and endometriosis-related healthcare resource utilization (HCRU) and healthcare costs by service categories (outpatient, inpatient, emergency room [ER], pharmacy) among patients with newly diagnosed endome…

article 2020
PMU33 THE IMPACT OF HIGH RISK AND CHRONIC OPOID USE AMONG COMMERCIALLY INSURED ENDOMETRIOSIS PATIENTS ON HEALTHCARE RESOURCE USE AND COSTS IN THE UNITED STATES
·doi:10.1016/j.jval.2020.04.808
article 2020
sj-pdf-1-whe-10.1177_1745506520965898 – Supplemental material for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
·doi:10.25384/sage.13488966.v1

Supplemental material, sj-pdf-1-whe-10.1177_1745506520965898 for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States by Stephani…

article 2020
sj-pdf-1-whe-10.1177_1745506520965898 – Supplemental material for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
·doi:10.25384/sage.13488966

Supplemental material, sj-pdf-1-whe-10.1177_1745506520965898 for The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States by Stephani…

other 2020
The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
·doi:10.25384/sage.c.5250771

Objectives:Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use…

other 2020
The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
·doi:10.25384/sage.c.5250771.v1

Objectives:Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid use…

article 2020
The impact of high-risk and chronic opioid use among commercially insured endometriosis patients on health care resource utilization and costs in the United States
Women's health (London, England) ·doi:10.1177/1745506520965898

OBJECTIVES: Evaluate all-cause and endometriosis-related health care resource utilization and costs among newly diagnosed endometriosis patients with high-risk versus low-risk opioid use or patients with chronic versus non-chronic opioid us…